Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research note issued to investors on Saturday. The firm issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reissued a “buy” rating and set a $6.00 price target on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Trading Up 0.7 %

Shares of NASDAQ RKDA opened at $2.76 on Friday. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $5.34. The company’s 50-day moving average price is $3.33 and its 200 day moving average price is $3.06. The stock has a market cap of $3.75 million, a price-to-earnings ratio of -0.64 and a beta of 1.27.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.